Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeDISINFECTION TECHNOLOGY PRODUCTSiCleanse Announces Collaboration with CIT to Offer Low-Interest Financing on All iCleanse Disinfection Products to Kill COVID

iCleanse Announces Collaboration with CIT to Offer Low-Interest Financing on All iCleanse Disinfection Products to Kill COVID

iCleanse www.icleanse.com, the leader in UV-C personal device disinfection, announced today that it has joined forces with CIT, a top 50 national bank, to provide low-interest financing on all iCleanse disinfection products to keep customers and staff safe from infectious pathogens.

This alliance allows iCleanse to better serve its current and future customer base, who may have limited cash flow due to the year-long pandemic, making UV-C disinfection more attainable for small and large businesses alike and keeping businesses open. iCleanse products kill 99.9% of infectious pathogens, such as COVID-19, the common cold, and influenza in as little as 15 seconds.

iCleanse’s Mission: Help Businesses Remain Safe and Open

iCleanse is the leader and only patented solution in chemical-free UV-C disinfection for mobile devices. Providing quick and effective disinfection for all types of business to help them remain safe and open is the main objective in iCleanse’s mission. Applying for financing through CIT is quick and easy, and customers can receive a decision on financing often in less than three minutes.

“Being able to offer our customers an easy financial solution to purchase our products is a no-brainer,” said Chris Allen, CEO of iCleanse. “Ensuring easy and effective disinfection of the items we use daily is one way to reduce the spread of the COVID-19 pandemic.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy